Heart failure & cardiomyopathiesMeta-analysis

Atrial Fibrillation Ablation in Heart Failure With Reduced vs Preserved Ejection Fraction

JAMA CardiolPublished

  • Systematic review and meta-analysis of randomised trials
  • random-effects Mantel-Haenszel models

Authors' conclusion

This study found that catheter ablation for AF was associated with reduced risk of HF events in patients with HFrEF but had limited or no benefit in HFpEF.

Study context

Population
Patients with heart failure (HF), NYHA class II or greater, and paroxysmal or persistent atrial fibrillation (AF) (heart failure with reduced ejection fraction (HFrEF) n = 1552; HF with preserved ejection fraction (HFpEF) n = 913)
Participants
2,465 patients · 12 randomized clinical trials (RCTs)
Comparison
Catheter ablation vs Conventional rate or rhythm control
Outcome
HF events:
  • HF hospitalization
  • Clinically significant worsening of HF
  • Unscheduled visits for treatment intensification

Pooled result

As reported in the abstract

HF events by HF phenotype
Catheter ablation vs Conventional rate or rhythm controlRelative risk (95% CI)
HFrEF
0.59(0.48–0.72)
HFpEF
0.93(0.65–1.32)

Further pooled results

OutcomeRR (95% CI)
CV death by HF phenotype — Catheter ablation vs Conventional rate or rhythm control · HFrEF0.49 (0.34–0.70)
CV death by HF phenotype — Catheter ablation vs Conventional rate or rhythm control · HFpEF0.91 (0.46–1.79)
All-cause mortality by HF phenotype — Catheter ablation vs Conventional rate or rhythm control · HFrEF0.63 (0.47–0.86)
All-cause mortality by HF phenotype — Catheter ablation vs Conventional rate or rhythm control · HFpEF0.95 (0.39–2.30)
  • CV death by HF phenotype: P for interaction = .12
  • All-cause mortality by HF phenotype: P for interaction = .39

Original publication

Atrial Fibrillation Ablation in Heart Failure With Reduced vs Preserved Ejection Fraction. JAMA Cardiol. Published 1 June 2024. doi:10.1001/jamacardio.2024.0675

Summarised from the published abstract; every number is checked against it